Atlas Trials

Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation

Clinical trial NCT01483274 · WITHDRAWN

Trial details

NCT number
NCT01483274
Sponsor
University of Louisville
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myelogenous Leukemia
Start date
2015-03-01
Primary completion
2015-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.